Tech Company Financing Transactions
Jellagen Funding Round
Jellagen, based in St Mellons, secured $10.7 million from Cardiff Capital Region, Development Bank of Wales and Thai Union.
Transaction Overview
Company Name
Announced On
12/8/2022
Transaction Type
Venture Equity
Amount
$10,660,000
Round
Series A
Investors
Cardiff Capital Region (Lead Investor)
Development Bank of Wales (Lead Investor)
Thai Union (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the medical development of Collagen Type 0, an innovative and sustainable collagen biomaterial, and advance its program towards human trials and regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Jellagen Unit G6 Capital Business Park Parkway
St Mellons, CF3 2PY
UK
St Mellons, CF3 2PY
UK
Phone
Website
Email Address
Overview
Founded in 2015 by Professor Andrew Mearns Spragg, a Scottish marine biotechnology pioneer, Jellagen is a marine biotechnology company manufacturing Collagen Type 0 for medical and scientific research applications. It is our deep belief in building sustainable sources for critical biomaterials which do not carry the environmental and human health risks of traditional collagen sources. Since 2015, Jellagen has honed its proprietary technology, enhanced its product range, and extended its expertise.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Webb
Chief Marketing Officer
Adam Watts
Browse more venture capital transactions:
Prev: 12/8/2022: Zeraki venture capital transaction
Next: 12/8/2022: Makers venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs